Related Experiment Video
Updated: Feb 1, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
A new pleuromutilin candidate with potent antibacterial activity against Pasteurella multocida
Yunxing Fu1, Lijun Ma2, Yunpeng Yi1
1Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, PR China; Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou, 730050, China.
Abstract:
This study assessed the antimicrobial activity of 14-O-[(4,6-Diaminopyrimidine-2-yl) thioacetyl] mutilin (DPTM), a novel pleuromutilin candidate with a substituted pyrimidine moiety, against Pasteurella multocida. Minimum Inhibitory Concentration (MIC), Oxford Cup assay, and time-kill experiments were used to measure the activity of DPTM against P. multocida serotype A in vitro. We observed that DPTM was potent against Pasteurella multocida serotype A with the MIC value of 0.781 μg/mL. The mean inhibition-zone diameters of DPTM (50, 25, and 12.5 μg/mL) were 29.4, 24.2 and 20.1 mm, respectively. Time-kill experiments showed that the drug caused a rapid decline in the number of bacteria compared with the initial inoculum at 4 h and killed 94.6% of the bacteria during 24 h. Furthermore, DPTM activity was also assessed in a lung infection model challenged with 4.0 × 109 CFU/mL P. multocida serotype A. The results showed that DPTM significantly reduced mortality rate and bacterial load, and alleviated the pathological changes of lung. The antibacterial effect of DPTM found in this study suggested that it was useful in the prevention or control of pneumonia caused by P. multocida.
Insights
The novel antimicrobial 14-O-[(4,6-Diaminopyrimidine-2-yl) thioacetyl] mutilin (DPTM) shows potent activity against Pasteurella multocida serotype A. DPTM effectively reduced bacterial load and mortality in a lung infection model.
Area of Science:
- Veterinary Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Pasteurella multocida is a significant pathogen causing respiratory infections in animals.
- Novel antimicrobial agents are needed to combat bacterial infections, including those caused by P. multocida.
Purpose of the Study:
- To evaluate the in vitro and in vivo antimicrobial activity of 14-O-[(4,6-Diaminopyrimidine-2-yl) thioacetyl] mutilin (DPTM) against Pasteurella multocida serotype A.
Main Methods:
- Minimum Inhibitory Concentration (MIC) assays were performed to determine the lowest concentration of DPTM inhibiting bacterial growth.
- Oxford Cup assays measured the zone of inhibition produced by DPTM.
- Time-kill experiments assessed the rate of bacterial killing by DPTM.
- A mouse lung infection model was used to evaluate DPTM's efficacy in vivo.
Main Results:
- DPTM demonstrated potent in vitro activity against P. multocida serotype A, with a MIC of 0.781 μg/mL.
- Significant inhibition zones were observed in Oxford Cup assays.
- Time-kill experiments showed a rapid reduction in bacterial numbers, with 94.6% killing within 24 hours.
- In vivo, DPTM significantly reduced mortality, bacterial load, and lung pathology in a P. multocida-induced pneumonia model.
Conclusions:
- DPTM exhibits significant antimicrobial activity against Pasteurella multocida serotype A.
- DPTM shows promise as a therapeutic agent for controlling or preventing P. multocida-associated pneumonia.
More Related Videos
11:19Synthesis of Multi-walled Carbon Nanotubes Modified with Silver Nanoparticles and Evaluation of Their Antibacterial Activities and Cytotoxic Properties
Published on: May 10, 2018
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Co-activators and Co-repressors
tRNA Activation
Activation Energy
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Secondary Active Transport
Primary Active Transport